drugset / Trial / NCT04691076
Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy
RandomizedParallel-groupDouble-blindTreatment
Summary
Purpose: 1. To determine the efficacy of low-dose esketamine in painless gastrointestinal endoscopy. 2. To determine the safety of low-dose esketamine in painless gastrointestinal endoscopy. 3. To provide a theoretical basis and new ideas for the application of esketamine as a new drug in perioperative period.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2021-12-01
- Completion
- 2022-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.15 mg/kg | Intravenous |
| Comparator | Fentanyl | Other / unclassified | 0.6 ug/kg | Intravenous |
| Background | Propofol | Small molecule | 1.5 ug/ml | — |
Indications
No indication recorded.